Abstract:We have constructed a recombinant DNA clone containing the gene encoding glutamic acid decarboxylase (GAD), which catalyzes the synthesis of γ-aminobutyric acid (GABA). This recombinant DNA was then transfected into mouse NIH-3T3 fibroblast cells for transplantation into Swiss-Web mice. In order to construct a plasmid capable of transcribing the DNA insert in the eucaryotic cells, the GAD gene was removed from pSP65-13, and was ligated into the vector pSV2neo, which contains the SV40 early promoter, and the neomycin resistance gene. The pSV2GAD was then transfected into NIH-3T3 fibroblasts by calcium phosphate precipitation, or by electroporation. The transfected fibroblasts were then selected with antibiotic G418 for amplification. The transient expression of GAD in the transfected fibroblasts was detected by immunocytochemical staining using anti-GAD antibody. A small population of GAD immunoreactive cells were clearly stained, and were easily distinguished from the majority of unstained background cells. These GAD-immunoreactive cells were not seen in either mock-transfected, or pSV2neo-transfected cells (vector-alone control). The transfected fibroblasts were continuously selected with antibiotic G418. Six out of 35 subcultures that had GAD-positive immunostaining in the cell lines were selected. Granular GAD-positive staining was observed in the cytoplasm and fiber extensions of the transfected cell lines in varying densities. The GAD-mRNA was also detected in the subcultures by in situ hybridization using a 35S-labeled 369-nucleotide riboprobe in pBluescript. The GAD-transfected NIH-3T3 cells were then transplanted into Swiss-Web mice. Fifteen to 30 days later, transplanted animals were perfused for identification. These cells were first identified with anti-fibronectin antibody, and the adjacent sections with anti-GAD or anti-GABA antibodies. All the transplants are fibronectin-positive. Both GAD- and GABA positive cells were observed in the transplant.

Amplification of Human GAD67 Gene and Construction of Its Eukaryotic Expression Vector Pegfpc2-Gad67

Construction of HFV Vector-Mediated GAD Gene and Its Application

Transfection and initial detection of human GAD67 gene into bone marrow stromal cells-derived neural stem cells

Establishment of a Stable Glutamate Decarboxylase (gad) Expressing Cell-Line by Transfection

Construction of recombinant eukaryotic expression vector pEGFPN1-GDNF and its expression

The Experimental Study of Construction of Recombinant Plasmid Pegfp-Gdnf and Its Expression in Eukaryotic Cell

Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes.

Cloning, Sequencing and Expression of a Glutamate Decarboxylase Gene from the GABA-producing Strain Lactobacillus Brevis CGMCC 1306

Expression and Activity of Recombinant Human Glutamate Decarboxylase 65

A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury.

Efficient expression of novel glutamate decarboxylases and high level production of γ-aminobutyric acid catalyzed by engineered Escherichia coli

Construction and Identification of 2 Secreted Human GAD65 Fragment DNA Vaccines

Construction of the recombinant adenovirus vectors containing human glutathione peroxidase gene

Construction of Pcdna3.1(+) Glial Cell Line-Derived Neurotrophic Factor(gdnf) Vector and Its Expression in Eukaryotic Cells

Construction and Identification of Eukaryotic Expression Vector Containing GAD65 Fragment and IL-10 Gene

GDDR~(mut) vector construction and establishment of SGC-7901-GDD~(mut) stable cell lines

Construction of Recombinant Pichia Pastoris-Rat Glutamic Acid Decarboxylase(rgad)

Molecular Cloning and Expression of Human BDNF Gene Encoding Mature Peptide

[Construction of Eukaryotic Expression Vector for Human Glial Derived Neurotrophic Factor and Its Expression in Spinal Cord Tissue of SD Rat].

Expressing and ability protecting primary dopaminergic nerous of human GDNFcDNA in engineered SH-SY5Y cells

Construction and Identification of Human Glial Cell-Derived Neurotrophic Factor Gene-Modified Schwann Cells from Rhesus Monkeys